BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

229 related articles for article (PubMed ID: 6382999)

  • 1. Lipid Research Clinics Coronary Primary Prevention Trial: results and implications.
    Rifkind BM
    Am J Cardiol; 1984 Aug; 54(5):30C-34C. PubMed ID: 6382999
    [TBL] [Abstract][Full Text] [Related]  

  • 2. The Lipid Research Clinics Coronary Primary Prevention Trial results. I. Reduction in incidence of coronary heart disease.
    JAMA; 1984 Jan; 251(3):351-64. PubMed ID: 6361299
    [TBL] [Abstract][Full Text] [Related]  

  • 3. The Lipid Research Clinics Coronary Primary Prevention Trial.
    Rifkind BM
    Drugs; 1986; 31 Suppl 1():53-60. PubMed ID: 3720571
    [TBL] [Abstract][Full Text] [Related]  

  • 4. The Lipid Research Clinics Coronary Primary Prevention Trial results. II. The relationship of reduction in incidence of coronary heart disease to cholesterol lowering.
    JAMA; 1984 Jan; 251(3):365-74. PubMed ID: 6361300
    [TBL] [Abstract][Full Text] [Related]  

  • 5. High-density lipoprotein cholesterol and coronary heart disease in hypercholesterolemic men: the Lipid Research Clinics Coronary Primary Prevention Trial.
    Gordon DJ; Knoke J; Probstfield JL; Superko R; Tyroler HA
    Circulation; 1986 Dec; 74(6):1217-25. PubMed ID: 3536151
    [TBL] [Abstract][Full Text] [Related]  

  • 6. The Lipid Research Clinics Coronary Primary Prevention Trial: design, results, and implications.
    Probstfield JL; Rifkind BM
    Eur J Clin Pharmacol; 1991; 40 Suppl 1():S69-75. PubMed ID: 2044648
    [TBL] [Abstract][Full Text] [Related]  

  • 7. The Lipid Research Clinics Coronary Primary Prevention Trial: results and implications.
    Rifkind BM
    Monogr Atheroscler; 1985; 13():74-84. PubMed ID: 3911061
    [No Abstract]   [Full Text] [Related]  

  • 8. Report on the Lipid Research Clinic trials.
    Levy RI
    Eur Heart J; 1987 Aug; 8 Suppl E():45-53. PubMed ID: 3315677
    [TBL] [Abstract][Full Text] [Related]  

  • 9. The Lipid Research Clinics Coronary Primary Prevention Trial. Results of 6 years of post-trial follow-up. The Lipid Research Clinics Investigators.
    Arch Intern Med; 1992 Jul; 152(7):1399-410. PubMed ID: 1627020
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Dietary and other correlates of changes in total and low density lipoprotein cholesterol in hypercholesterolemic men: the lipid research clinics coronary primary prevention trial.
    Glueck CJ; Gordon DJ; Nelson JJ; Davis CE; Tyroler HA
    Am J Clin Nutr; 1986 Oct; 44(4):489-500. PubMed ID: 3532756
    [TBL] [Abstract][Full Text] [Related]  

  • 11. The influence of changes in lipid values induced by cholestyramine and diet on progression of coronary artery disease: results of NHLBI Type II Coronary Intervention Study.
    Levy RI; Brensike JF; Epstein SE; Kelsey SF; Passamani ER; Richardson JM; Loh IK; Stone NJ; Aldrich RF; Battaglini JW
    Circulation; 1984 Feb; 69(2):325-37. PubMed ID: 6360415
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Lipoprotein(a) levels and risk of coronary heart disease in men. The lipid Research Clinics Coronary Primary Prevention Trial.
    Schaefer EJ; Lamon-Fava S; Jenner JL; McNamara JR; Ordovas JM; Davis CE; Abolafia JM; Lippel K; Levy RI
    JAMA; 1994 Apr; 271(13):999-1003. PubMed ID: 8139085
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Commentary on the published results of the Lipid Research Clinics Coronary Primary Prevention Trial.
    Kronmal RA
    JAMA; 1985 Apr; 253(14):2091-3. PubMed ID: 3883022
    [No Abstract]   [Full Text] [Related]  

  • 14. Primary prevention of coronary heart disease by lowering lipids: results and implications.
    Levy RI
    Am Heart J; 1985 Nov; 110(5):1116-22. PubMed ID: 3904377
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Serum carotenoids and coronary heart disease. The Lipid Research Clinics Coronary Primary Prevention Trial and Follow-up Study.
    Morris DL; Kritchevsky SB; Davis CE
    JAMA; 1994 Nov; 272(18):1439-41. PubMed ID: 7933426
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Pre-entry characteristics of participants in the Lipid Research Clinics' Coronary Primary Prevention Trial.
    J Chronic Dis; 1983; 36(6):467-79. PubMed ID: 6863470
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Low-dose combined therapy with fluvastatin and cholestyramine in hyperlipidemic patients.
    Sprecher DL; Abrams J; Allen JW; Keane WF; Chrysant SG; Ginsberg H; Fischer JJ; Johnson BF; Theroux P; Jokubaitis L
    Ann Intern Med; 1994 Apr; 120(7):537-43. PubMed ID: 8093139
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Cholesterol-lowering therapy after heart transplantation: a 12-month randomized trial.
    Pflugfelder PW; Huff M; Oskalns R; Rudas L; Kostuk WJ
    J Heart Lung Transplant; 1995; 14(4):613-22. PubMed ID: 7578166
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Changes in plasma apolipoprotein B-containing lipoparticle levels following therapy with fluvastatin and cholestyramine. European Fluvastatin Study Group.
    Bard JM; Ose L; Hagen E; Duriez P; Pfister P; Fruchart JC; Dallongeville J
    Am J Cardiol; 1995 Jul; 76(2):65A-70A. PubMed ID: 7604802
    [TBL] [Abstract][Full Text] [Related]  

  • 20. A multicenter comparison of lovastatin and cholestyramine therapy for severe primary hypercholesterolemia. The Lovastatin Study Group III.
    JAMA; 1988 Jul; 260(3):359-66. PubMed ID: 2898027
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 12.